placebo + zolpidem + zolpidem

Phase 1Completed

0 watching 0 views this week💤 Quiet

Hype Score

Development Stage

✓

Pre-clinical

Phase 1

Phase 2

Phase 3

Approved

Indication / Disease

Methodology Study

Conditions

Methodology Study

Trial Timeline

Jul 1, 2008 → Oct 1, 2008

NCT ID

NCT00716521

About placebo + zolpidem + zolpidem

placebo + zolpidem + zolpidem is a phase 1 stage product being developed by Pfizer for Methodology Study. The current trial status is completed. This product is registered under clinical trial identifier NCT00716521. Target conditions include Methodology Study.

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (1)

NCT ID	Phase	Status	Start	Completion	Indication
NCT00716521	Phase 1	Completed	Jul 1, 2008	Oct 1, 2008	Methodology Study

Competing Products

1 competing product in Methodology Study

See all competitors

Product	Company	Stage	Hype Score
Comparator: exenatide + Comparator: exenatide + Comparator: Placebo	Merck	Phase 1	33

Other Products from Pfizer